Animal models described in Tables 1-3 stand in contrast to those described in Supplementary Table 1a and 1b (36); these models either exhibit PCOS-like traits alongside other PCOS-excluding endocrinopathies, such as hyperprolactinemia and hypogonadotropic amenorrhea, including luteinizing hormone (LH)-β overexpressing mice and dehydroepiandrosterone (DHEA)-treated prepubertal or adult female rodents (32, 38, 39), or less than two traits approximating biomarkers for Rotterdam equivalent criteria, such as T-treated neonatal rats (38, 40). The gene discussed is LHB; the disease is polycystic ovary syndrome.